MEDEXPRESS ENTERPRISES LTDActive
Key figures
MEDEXPRESS ENTERPRISES LTD does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2023Balance sheet structure
Filed accounts2020–2023
| 2020 | 2021 | 2023 | |
|---|---|---|---|
| Turnover | — | 13,109,930 | — |
| Profit for the year | — | 1,977,826 | -1,553,642 |
| Cash at bank and in hand | 515,483 | 634,878 | 1,464,835 |
| Total assets | 6,746,048 | 9,012,095 | 9,819,842 |
| Total liabilities | — | 1,267,813 | 1,339,656 |
| Net assets / total equity | 5,887,431 | 8,050,672 | 8,420,663 |
| Average number of employees | 51 | 79 | 174 |
| Average pay (per year) | — | 46,542 | 63,906 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2023The principal activity of the company continued to be that of providing consumer health services.
As described in the company's latest filed accounts.
Summary: MEDEXPRESS ENTERPRISES LTD
Company
MEDEXPRESS ENTERPRISES LTD is a private limited company registered with Companies House under company number 08805262. It was incorporated on 6 Dec 2013. Its status is active. The registered office is in Leamington spa (CV31). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).
Accounts
The latest accounts in the database are for 2023 (period ending 31 Dec 2023); the company files audit-exempt subsidiary. Loss for the year was £1,553,642. Net assets were £8,420,663, up 4.6% on the previous year. Cash at bank and in hand was £1,464,835. Total assets were £9,819,842 and total liabilities £1,339,656. The company had an average of 174 employees. Figures are available for 3 financial years (2020–2023).
Control and charges
One person with significant control is registered. 2 of 3 registered charges are outstanding.
Filing deadlines
The next accounts are due by 30 Sep 2026. The next confirmation statement is due by 20 Dec 2026.